Jadimurthy Ragi, Jagadish Swamy, Nayak Siddaiah Chandra, Kumar Sumana, Mohan Chakrabhavi Dhananjaya, Rangappa Kanchugarakoppal S
Department of Studies in Molecular Biology, University of Mysore, Manasagangotri, Mysore 570006, India.
Department of Studies in Biotechnology, University of Mysore, Manasagangotri, Mysore 570006, India.
Life (Basel). 2023 Apr 4;13(4):948. doi: 10.3390/life13040948.
Plants have been used for therapeutic purposes against various human ailments for several centuries. Plant-derived natural compounds have been implemented in clinics against microbial diseases. Unfortunately, the emergence of antimicrobial resistance has significantly reduced the efficacy of existing standard antimicrobials. The World Health Organization (WHO) has declared antimicrobial resistance as one of the top 10 global public health threats facing humanity. Therefore, it is the need of the hour to discover new antimicrobial agents against drug-resistant pathogens. In the present article, we have discussed the importance of plant metabolites in the context of their medicinal applications and elaborated on their mechanism of antimicrobial action against human pathogens. The WHO has categorized some drug-resistant bacteria and fungi as critical and high priority based on the need to develope new drugs, and we have considered the plant metabolites that target these bacteria and fungi. We have also emphasized the role of phytochemicals that target deadly viruses such as COVID-19, Ebola, and dengue. Additionally, we have also elaborated on the synergetic effect of plant-derived compounds with standard antimicrobials against clinically important microbes. Overall, this article provides an overview of the importance of considering phytogenous compounds in the development of antimicrobial compounds as therapeutic agents against drug-resistant microbes.
几个世纪以来,植物一直被用于治疗各种人类疾病。植物衍生的天然化合物已在临床上用于对抗微生物疾病。不幸的是,抗菌药物耐药性的出现显著降低了现有标准抗菌药物的疗效。世界卫生组织(WHO)已将抗菌药物耐药性列为人类面临的十大全球公共卫生威胁之一。因此,当下迫切需要发现针对耐药病原体的新型抗菌药物。在本文中,我们讨论了植物代谢物在其药用应用背景下的重要性,并阐述了它们对人类病原体的抗菌作用机制。基于开发新药的需求,WHO已将一些耐药细菌和真菌归类为关键和高度优先级别,我们考虑了针对这些细菌和真菌的植物代谢物。我们还强调了针对COVID-19、埃博拉和登革热等致命病毒的植物化学物质的作用。此外,我们还阐述了植物衍生化合物与标准抗菌药物对临床上重要微生物的协同作用。总体而言,本文概述了在开发抗菌化合物作为抗耐药微生物治疗剂时考虑植物源化合物的重要性。